Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-07 4:30 pm Purchase | 2021-05-26 | 13G | Provention Bio, Inc. PRVB | Venrock Healthcare Capital Partners II, L.P. | 3,843,796 6.100% | 3,843,796 (New Position) | Filing History |
| 2021-04-15 4:09 pm Purchase | 2021-03-23 | 13G | Instil Bio, Inc. TIL | Venrock Healthcare Capital Partners II, L.P. | 343,254 5.400% | 343,254 (New Position) | Filing History |
| 2021-03-01 4:07 pm Sale | 2021-02-25 | 13G | Altimmune, Inc. ALT | Venrock Healthcare Capital Partners II, L.P. | 3,622,964 9.990% | -877,036 (-19.49%) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 474,675 9.990% | 474,675 (New Position) | Filing History |
| 2021-02-16 4:10 pm Sale | 2020-12-31 | 13G | Surface Oncology, Inc. SURF | Venrock Healthcare Capital Partners II, L.P. | 1,442,895 3.500% | -2,435,000 (-62.79%) | Filing History |
| 2021-02-16 4:10 pm Sale | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Venrock Healthcare Capital Partners II, L.P. | 668,440 4.100% | -214,374 (-24.28%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Venrock Healthcare Capital Partners II, L.P. | 2,588,941 7.300% | 963,231 (+59.25%) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Athira Pharma, Inc. ATHA | Venrock Healthcare Capital Partners II, L.P. | 169,162 5.200% | 3,400 (+2.05%) | Filing History |